Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 83086J200 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
5AM Partners VII, LLC
13D/A
Amendment 5
|
30.2% |
8/18/2026
Event 8/14/2026
|
|
| 5AM Partners VII, LLC | 25.9% | ||
| 5AM Ventures VII, L.P. | 25.9% | ||
| 5AM Partners II, LLC | 4.1% | ||
| 5AM Ventures II, L.P. | 4.0% | ||
| 5AM Co-Investors II, L.P. | 0.2% | ||
| Andrew J. Schwab | 30.2% | ||
| Kush Parmar | 25.9% | ||
| John D. Diekman | 4.1% | ||
| Scott M. Rocklage | 4.1% | ||
|
5AM Partners VII, LLC
13D/A
Amendment 4
|
34.0% |
12/16/2025
Event 12/12/2025
|
|
| 5AM Partners VII, LLC | 29.2% | ||
| 5AM Ventures VII, L.P. | 29.2% | ||
| 5AM Partners II, LLC | 4.7% | ||
| 5AM Ventures II, L.P. | 4.5% | ||
| 5AM Co-Investors II, L.P. | 0.2% | ||
| Andrew J. Schwab | 34.0% | ||
| Kush Parmar | 29.2% | ||
| John D. Diekman | 4.7% | ||
| Scott M. Rocklage | 4.7% | ||
| Schonfeld Strategic Advisors LLC 13G/A Amendment 1 | 3.6% |
8/14/2025
Event 6/30/2025
|
|
| Schonfeld Strategic Advisors LLC 13G | 5.2% |
5/15/2025
Event 3/31/2025
|
|
|
Sphera Funds Management Ltd.
13G/A
Amendment 1
|
4.8% |
4/10/2025
Event 3/31/2025
|
|
| Sphera Funds Management Ltd. | 4.8% | ||
| Sphera Global Healthcare GP Ltd. | 4.8% | ||
| Sphera Global Healthcare Management LP. | 4.8% | ||
|
5AM Partners VII, LLC
13D/A
Amendment 3
|
36.4% |
12/19/2024
Event 12/17/2024
|
|
| 5AM Partners VII, LLC | 30.8% | ||
| 5AM Ventures VII, L.P. | 30.8% | ||
| 5AM Partners II, LLC | 5.8% | ||
| 5AM Ventures II, L.P. | 5.5% | ||
| 5AM Co-Investors II, L.P. | 0.2% | ||
| Andrew J. Schwab | 36.4% | ||
| Kush Parmar | 30.8% | ||
| John D. Diekman | 5.8% | ||
| Scott M. Rocklage | 5.8% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 44 | 16.0 M | $11.1 M |
| 2026 Q1 | 41 | 16.1 M | $9.91 M |
| 2025 Q4 | 52 | 16.1 M | $12.1 M |
| 2025 Q3 | 66 | 19.9 M | $78.1 M |
| 2025 Q2 | 65 | 20.4 M | $85.3 M |
| 2025 Q1 | 79 | 24.7 M | $39.3 M |
| 2024 Q4 | 75 | 25.2 M | $71.3 M |
| 2024 Q3 | 79 | 25.7 M | $101 M |
| 2024 Q2 | 68 | 25.8 M | $207 M |
| 2024 Q1 | 4 | 2.01 M | $31.4 M |
| 2023 Q4 | 1 | 1.60 k | $4.35 k |